Plain-English translation of NCT05024214 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Solid Tumors research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new combination of two medications: envafolimab and lenvatinib. Researchers want to see if taking these two drugs together can help people whose advanced cancer has either stopped responding to previous treatments or cannot be treated with standard options. The study will measure how many people's tumors shrink and how safe this combination is.
Many people with advanced cancers run out of treatment options when their disease stops responding to standard therapies. This medication combination represents a new approach that may help patients who have already tried other treatments without success.
You likely qualify if…
You likely don't qualify if…
Participants will take the medication by mouth and visit the study center regularly so doctors can monitor how well the treatment is working and check for side effects. The study has two phases: an initial phase to find the right dose, followed by a larger phase testing the combination in people with specific cancer types. Your exact schedule and duration will depend on which group you join and how your cancer responds to treatment.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China